High-affinity fluorescent ligands for the 5-HT3 receptor

被引:17
|
作者
Simonin, Jonathan [1 ]
Vernekar, Sanjeev Kumar V. [2 ]
Thompson, Andrew J. [3 ]
Hothersall, J. Daniel [4 ]
Connolly, Christopher N. [4 ]
Lummis, Sarah C. R. [3 ]
Lochner, Martin [1 ]
机构
[1] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland
[2] Univ Minnesota, Ctr Drug Design, Minneapolis, MN 55455 USA
[3] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England
[4] Univ Dundee, Ninewells Med Sch, Med Res Inst, Ctr Neurosci, Dundee DD1 9SY, Scotland
基金
瑞士国家科学基金会; 英国工程与自然科学研究理事会; 英国惠康基金;
关键词
5-HT3; receptor; Cys-loop ligand-gated ion channels; Fluorescent ligands; Radioligand binding; In vivo imaging; ANTAGONISTS;
D O I
10.1016/j.bmcl.2011.11.097
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis, photophysical and biological characterization of a small library of fluorescent 5-HT3 receptor ligands is described. Several of these novel granisetron conjugates have high quantum yields and show high affinity for the human 5-HT(3)AR. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1151 / 1155
页数:5
相关论文
共 50 条
  • [1] High affinity ligands for the α7 nicotinic receptor that show no cross-reactivity with the 5-HT3 receptor
    Baker, SR
    Boot, J
    Brunavs, M
    Dobson, D
    Green, R
    Hayhurst, L
    Keenan, M
    Wallace, L
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (21) : 4727 - 4730
  • [2] Selective 5-HT3 receptor ligands
    Terrett, N
    [J]. DRUG DISCOVERY TODAY, 1996, 1 (10) : 448 - 448
  • [3] 1-(M-CHLOROPHENYL)-BIGUANIDE, A POTENT HIGH-AFFINITY 5-HT3 RECEPTOR AGONIST
    KILPATRICK, GJ
    BUTLER, A
    BURRIDGE, J
    OXFORD, AW
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 182 (01) : 193 - 197
  • [4] DEVELOPMENT OF HIGH-AFFINITY 5-HT3 RECEPTOR ANTAGONISTS .2. 2 NOVEL TRICYCLIC BENZAMIDES
    YOUSSEFYEH, RD
    CAMPBELL, HF
    AIREY, JE
    KLEIN, S
    SCHNAPPER, M
    POWERS, M
    WOODWARD, R
    RODRIGUEZ, W
    GOLEC, S
    STUDT, W
    DODSON, SA
    FITZPATRICK, LR
    PENDLEY, CE
    MARTIN, GE
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (05) : 903 - 911
  • [5] MOLECULAR MODELING OF 5-HT3 RECEPTOR LIGANDS
    EVANS, SM
    GALDES, A
    GALL, M
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 40 (04) : 1033 - 1040
  • [6] A review of fluorescent ligands for studying 5-HT3 receptors
    Lochner, Martin
    Thompson, Andrew J.
    [J]. NEUROPHARMACOLOGY, 2015, 98 : 31 - 40
  • [7] Bivalent Ligands for the Serotonin 5-HT3 Receptor
    Cappelli, Andrea
    Manini, Monica
    Paolino, Marco
    Gallelli, Andrea
    Anzini, Maurizio
    Mennuni, Laura
    Del Cadia, Marta
    De Rienzo, Francesca
    Menziani, M. Cristina
    Vomero, Salvatore
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (08): : 571 - 576
  • [8] New arylpiperazine derivatives with high affinity for 5-HT3 receptor sites
    Castan, F
    Schambel, P
    Enrici, A
    Rolland, F
    Bigg, DCH
    [J]. MEDICINAL CHEMISTRY RESEARCH, 1996, 6 (02) : 81 - 101
  • [9] Characterization of a novel, high-affinity and selective fluorescent antagonist for the 5HT1A receptor
    Fatokun, Amos Akintayo
    Middleton, Richard J.
    Thompson, Kevin S. J.
    Briddon, Stephen J.
    Hill, Stephen J.
    [J]. FASEB JOURNAL, 2013, 27
  • [10] DEVELOPMENT OF HIGH-AFFINITY 5-HT3 RECEPTOR ANTAGONISTS .1. INITIAL STRUCTURE ACTIVITY RELATIONSHIP OF NOVEL BENZAMIDES
    YOUSSEFYEH, RD
    CAMPBELL, HF
    KLEIN, S
    AIREY, JE
    DARKES, P
    POWERS, M
    SCHNAPPER, M
    NEUENSCHWANDER, K
    FITZPATRICK, LR
    PENDLEY, CE
    MARTIN, GE
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (05) : 895 - 903